Moderna (NASDAQ: MRNA) insider sale: 53,336 shares via option exercise
Rhea-AI Filing Summary
Moderna, Inc. submitted a Form 144 notice relating to the proposed sale of 53,336 shares of Common Stock on 06/15/2026, identified as a Stock Option Exercise with cash settlement. The filing shows a prior sale by Stephen Hoge of 53,336 shares on 05/15/2026 for $2,581,462.40.
The filing lists a purchaser/recipient line for Fidelity Brokerage Services LLC and numeric values of $2,739,870.32 and 396,786,259 appearing in the excerpt; the document links the shares and exercise method to the issuer and cash settlement.
Positive
- None.
Negative
- None.
Insights
Form 144 notice documents a proposed sale of 53,336 shares via option exercise.
The excerpt shows a Stock Option Exercise dated 06/15/2026 and identifies 53,336 shares to be sold with cash proceeds treatment. A prior sale by Stephen Hoge of the same share count on 05/15/2026 for $2,581,462.40 is also listed.
Such Form 144 filings are routine compliance notices under resale rules; subsequent broker reporting or a Form 4/5 may provide definitive transaction settlement details.
The transaction is characterized in the excerpt as issuer-related option exercise with cash proceeds.
The excerpt ties the method to the issuer and indicates cash as the settlement method. It also names Fidelity Brokerage Services LLC in the securities line and shows monetary figures that appear tied to the sale/exercise amounts.
Timing and final cash-flow recipients are disclosed in the lines shown; definitive settlement and reporting will appear in trade confirmations or subsequent SEC filings.